To further investigate this potential mechanism, we treated alveolar type 2 cells with TGFβ in the absence or presence of the synthetic TLR3 agonist, polyinosinic:polycytidylic acid (poly I:C), to mimic viral infection. This evidence concerns the gene TGFB1 and viral infectious disease.